QALYs: The Basics

被引:505
作者
Weinstein, Milton C. [1 ]
Torrance, George [2 ]
McGuire, Alistair [3 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA
[2] McMaster Univ, Hamilton, ON, Canada
[3] London Sch Econ, London WC2A 2AE, England
基金
美国医疗保健研究与质量局;
关键词
quality-adjusted life-year; cost-effectiveness analysis; preference; utility; standard gamble; time trade-off; taxonomy; theory; HEALTHY-YEARS EQUIVALENTS; ADJUSTED LIFE YEARS; UTILITY;
D O I
10.1111/j.1524-4733.2009.00515.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:S5 / S9
页数:5
相关论文
共 11 条
  • [1] Making descriptive use of prospect theory to improve the prescriptive use of expected utility
    Bleichrodt, H
    Pinto, JL
    Wakker, PP
    [J]. MANAGEMENT SCIENCE, 2001, 47 (11) : 1498 - 1514
  • [2] Interpretations of utility and their implications for the valuation of health
    Dolan, Paul
    Kahneman, Daniel
    [J]. ECONOMIC JOURNAL, 2008, 118 (525) : 215 - 234
  • [3] HEALTH-STATUS INDEX AND ITS APPLICATION TO HEALTH-SERVICES OUTCOMES
    FANSHEL, S
    BUSH, JW
    [J]. OPERATIONS RESEARCH, 1970, 18 (06) : 1021 - &
  • [4] ARE HEALTHY-YEARS EQUIVALENTS AN IMPROVEMENT OVER QUALITY-ADJUSTED LIFE YEARS
    JOHANNESSON, M
    PLISKIN, JS
    WEINSTEIN, MC
    [J]. MEDICAL DECISION MAKING, 1993, 13 (04) : 281 - 286
  • [5] QUALITY-ADJUSTED LIFE YEARS, UTILITY-THEORY, AND HEALTHY-YEARS EQUIVALENTS
    MEHREZ, A
    GAFNI, A
    [J]. MEDICAL DECISION MAKING, 1989, 9 (02) : 142 - 149
  • [6] QALYs: Some Challenges
    Nord, Erik
    Daniels, Norman
    Kamlet, Mark
    [J]. VALUE IN HEALTH, 2009, 12 : S10 - S15
  • [7] Recommendations for reporting cost-effectiveness analyses
    Siegel, JE
    Weinstein, MC
    Russell, LB
    Gold, MR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16): : 1339 - 1341
  • [8] Sutherland H J, 1982, Med Decis Making, V2, P299, DOI 10.1177/0272989X8200200306
  • [9] Torrance G W, 1972, Health Serv Res, V7, P118
  • [10] Utility measurement in healthcare - The things I never got to
    Torrance, George W.
    [J]. PHARMACOECONOMICS, 2006, 24 (11) : 1069 - 1078